Scherr et al [129] evaluated the expression of two key regulators of apoptosis, bcl2 and p53, by immunohistochemical staining on pre-treatment needle biopsies from 54 patients who were later treated with radiotherapy for localized prostate cancer. This evidence concerns the gene BCL2 and prostate carcinoma.